Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDNA | Common Stock | Sale | -$179K | -11.1K | -1.97% | $16.13 | 552K | Feb 9, 2023 | Direct | F1, F2 |
transaction | CDNA | Common Stock | Sale | -$131K | -8.49K | -1.54% | $15.48 | 543K | Feb 10, 2023 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.03 to $16.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.31 to $15.68, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
President and Chief Executive Officer